logo
RFK-backed ostrich farm fighting H5N1 cull boasted of turning birds into pet food

RFK-backed ostrich farm fighting H5N1 cull boasted of turning birds into pet food

Yahoo2 days ago

An H5N1-infected ostrich farm which has become a cause célèbre among animal rights campaigners and the US health secretary, Robert F. Kennedy Jr, once boasted of 'rendering' the birds down in vats so that their oil could be used in cosmetics and pet food.
Universal Ostrich Farms, located in British Columbia, made headlines earlier this month after its owners claimed they were being unfairly ordered to cull their flock of around 400 birds by the Canadian Food Inspection Agency (CFIA).
The cull order came after the CFIA said that several of the animals had contracted H5N1, the deadly avian flu virus that has decimated bird populations worldwide and which experts fear could one day jump to humans.
Thousands of similar cull orders have been issued to infected farms around the world as the virus has spread, but the Canadian ostriches appear to have won a brief stay of execution after being swept up in the US-Canadian culture wars.
A 'Save our Ostriches' campaign launched by the farm's owners has been jumped on by both animal rights activists and MAGA supporters in the US.
Some 69 ostriches have died on the farm since an outbreak began in December last year, when PCR testing came back positive for H5N1.
The farm's owners demanded the CFIA carry out further testing but their request was denied, and they are now claiming that the remaining birds have developed 'herd immunity,' catching the eye of RFK Jr, who has petitioned to have the birds relocated to Florida for further testing.
Scientists have called the proposal both dangerous and irresponsible, given the serious risks any infected birds pose to public health.
The farm's new 'Save Our Ostriches' website certainly pulls at the heartstrings but the contrast with the original website, still available through the internet archive, could not be sharper.
While the new site urges readers to donate up to $1,000 or more to save the 398 remaining birds, the original site talked of 'processing and rendering' and selling the 'meat, skin and oil' of ostriches all over the world.
'Full vertical integration improves quality, increases efficiency, and boosts profitability,' the original website reads.
'Help save Anna. She's feisty, confident, and always full of attitude,' says the new, MAGA-friendly site today, beneath a cutesy picture of a fluffy and determined looking bird.
Ostrich meat is imported and sold in Britain, including at major supermarkets but it is not clear if burgers and steaks from Universal Ostrich Farms were ever sold here.
In British Columbia, Katie Pasitney, the daughter of one of the farm's owners, Karen Espersen, and now acting spokesperson for both her mother and business partner Dave Bilinski, has appeared in several emotional videos in recent weeks appealing for public help and support.
The farm says the birds have not been used for meat since 2020, and are now mainly involved in medical research – specifically, the extraction of antibodies from ostrich eggs.
However, official court documents from the recent dispute with CFIA contradict this claim. They state that 'some level of ostrich sales, along with sales or planned sales of products derived from ostrich fat and eggshells, continued through to at least December 2024'.
The H5N1 avian flu virus was first detected in the late 1990s, but has spread rapidly through animal populations since 2020, killing millions of wild and farmed birds as well as a huge range of mammals – including polar bears, rhinos, whales, foxes, as well as domestic pets including cats and dogs.
Thousands of poultry farms around the world – including in Britain – have been forced to cull their flocks, causing the price of eggs to skyrocket to unprecedented levels.
Last year, the virus 'jumped' into the US cattle chain and since has become endemic. More than 1,000 dairy herds have been infected with the virus, and a fifth of the country's milk supply now contains detectable traces of H5N1.
At least 70 people in the US, mostly poultry and dairy farm workers, have also caught the virus, one of whom has died.
The virus's exponential spread comes at a time when the Trump administration has dramatically cut back on the government's response to H5N1.
Just last week, the administration announced it had cancelled a $766 million contract with pharmaceutical giant Moderna for the mass-production of mRNA bird flu vaccines. The agreement was intended to strengthen the country's pandemic preparedness by diversifying its emergency H5N1 vaccine stocks.
RFK Jr, a long-time vaccine sceptic, has repeatedly expressed concerns over the safety of mRNA vaccines despite them having saved millions of lives during the Covid-19 pandemic.
President Trump has also cut funding to several departments at the US Department of Agriculture and Centre for Disease Control responsible for monitoring and containing the spread of H5N1.
It makes RFK Jr's intervention into the Canadian ostriches' fate even more baffling. 'We believe significant scientific knowledge may be garnered from following the ostriches in a controlled environment,' Mr Kennedy wrote in a letter to the head of the Canadian Food Inspection Agency.
Experts say the scientific value of the ostriches is minimal, as similar studies have already been conducted in other parts of the world, and transporting any sickened birds would put people and other farms at risk.
In a statement published over the weekend, the CFAI said: '[Our] response to highly pathogenic avian influenza in domestic poultry is based on an approach known as 'stamping-out', as defined by the World Organisation for Animal Health (WOAH).
'Stamping-out is the internationally recognised standard and is a primary tool to manage the spread of [H5N1] and mitigate risks to animal and human health as well as enable international trade.'
'Given that the flock has had multiple laboratory-confirmed cases of H5N1 and the ongoing serious risks for animal and human health, and trade, the CFIA continues planning for depopulation at the infected premises'.
The Telegraph contacted Universal Ostrich Farms for comment.
Protect yourself and your family by learning more about Global Health Security
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US vetoes UN ceasefire resolution in Gaza
US vetoes UN ceasefire resolution in Gaza

Yahoo

time39 minutes ago

  • Yahoo

US vetoes UN ceasefire resolution in Gaza

The US vetoed a United Nations Security Council resolution calling for an immediate ceasefire in Gaza. All 14 other members backed the measure, but the US voted against, saying that the wording did not condemn Hamas. US-Israel relations have cooled in recent months — President Donald Trump did not visit the country during his recent Middle East tour, and his relationship with Prime Minister Benjamin Netanyahu is tense, with disagreements including over the best way to deal with Iran. But Washington remains firmly behind Israel on the war, to the frustration of the UN: Its humanitarian chief said the scenes of people being 'shot, wounded or killed in Gaza while simply trying to eat' were 'horrifying.'

Asia-Pacific Transdermal Skin Patches Market Outlook 2025-2033: Trends for Pain Relief, Smoking Reduction & Cessation Aid, Overactive Bladder, Hormonal Therapy, and Other Applications
Asia-Pacific Transdermal Skin Patches Market Outlook 2025-2033: Trends for Pain Relief, Smoking Reduction & Cessation Aid, Overactive Bladder, Hormonal Therapy, and Other Applications

Yahoo

time44 minutes ago

  • Yahoo

Asia-Pacific Transdermal Skin Patches Market Outlook 2025-2033: Trends for Pain Relief, Smoking Reduction & Cessation Aid, Overactive Bladder, Hormonal Therapy, and Other Applications

Innovations in microneedle and smart patch technologies are boosting efficacy and compliance, while government healthcare initiatives enhance access. Major players include Teva Pharmaceutical, 3M, and Johnson & Johnson. Growth is notably strong in China, India, and Japan due to demographic and health trends. Asia-Pacific Transdermal Skin Patches Market Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Transdermal Skin Patches Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" has been added to Asia-Pacific Transdermal Skin Patches Market is expected to reach US$ 3.96 billion by 2033 from US$ 2.76 billion in 2024, with a CAGR of 4.10% from 2025 to 2033. Increasing prevalence of chronic diseases, aging population, requirement for pain-free drug delivery, technological innovation, growth in healthcare infrastructure, and rising awareness of self-administered therapies that ensure convenience and improved patient compliance are the key drivers of the transdermal skin patches market in Asia-Pacific. Several significant factors are behind the consistent rise of the transdermal skin patch market in Asia-Pacific. The increasing prevalence of chronic conditions such as diabetes, hypertension, and cardiovascular disease is a key driver, since it increases the need for safe, non-invasive drug delivery systems. Increased demand for user-friendly and convenient pharmaceutical solutions is also being driven by the ageing population in the region, most notably in countries such as China and Japan. Efficiency in drug delivery and compliance among patients are being enhanced by advances in technology in the form of smart patches and microneedle technology. In addition, the application of transdermal therapies in the region is being encouraged and access enhanced by government healthcare initiatives as well as increases in healthcare infrastructure. Growth Drivers for the Asia-Pacific Transdermal Skin Patches MarketRising prevalence of respiratory disease The Asian Pacific market for transdermal skin patches is growing largely because of the rising prevalence of chronic diseases. Owing to sedentary lifestyles, environmental influences, and aging populations, chronic conditions such as diabetes, cardiovascular diseases, COPD, and cancer are on the rise. The incidence of chronic obstructive pulmonary disease (COPD) in Indian non-smokers, for instance, ranged from 1.6% to 26.6%, a meta-analysis study published in the Reviews on Environmental Health journal in November 2023 revealed. Also, India detects over 1.39 million new cancer cases every year, the Kidwai Memorial Institute of Oncology says. Long-term medication is often required for most diseases, and transdermal patches offer a steady, non-invasive, and effective route of drug delivery that enhances patient compliance. Demand for effective and convenient treatment options, like transdermal patches, is expected to grow tremendously across the region as the incidence of chronic diseases rises. Technological Advancements The Asia-Pacific market for transdermal skin patches is growing with a swift pace due to technology advancements that raise patient comfort, therapeutic efficacy, and medication administration effectiveness. Transdermally treatable disorders have widened as a result of innovations such as microneedle patches, sensor-embedded smart patches, and better adhesives. These technologies enhance patient compliance, especially among the elderly and the chronically ill, through the delivery of controlled, sustained, and painless medication. Teikoku Seiyaku Co. Ltd. and Kowa Company Ltd.'s April 2023 marketing in Japan of ALLYDONE Patches 27.5 mg and 55 mg for the treatment of dementia caused by Alzheimer's disease is a good case in point. This launch highlights how innovative patch technologies can be employed to treat neurologic diseases. These technological innovations are expected to greatly boost the adoption of transdermal patches across the Asia-Pacific market as research and development proceed. Ageing Population The aging population of the Asia-Pacific region is one of the key drivers of the market for transdermal skin patches. The demand for non-invasive, easy-to-use medicine delivery methods is increasing as the elderly population grows, especially in countries such as China and Japan. China's National Bureau of Statistics announced in January 2022 that the nation's population would be around 1.412 billion in 2021 and is likely to increase to 1.43 billion by the year 2026. Due to their ease of use, sustained drug delivery, and minor side effects, transdermal patches are a preferred option for this aging group, which is often required to take long-term medication for ongoing diseases. The demand for transdermal patches in the region is being fueled by the ability to administer medicine oneself without constant hospital visits, which fits the demands of an aging population. The demand for these advanced distribution systems is expected to evolve further as the number of elderly individuals increases. Challenges in the Asia-Pacific Transdermal Skin Patches MarketLimited Drug Permeability One major obstacle facing the Asia-Pacific transdermal skin patch business is limited medication permeability. The kinds of pharmaceuticals that can be administered via patches are limited by the ineffectiveness of certain drugs un penetrating the epidermal barrier. This restriction lessens the transdermal patches' adaptability and keeps them from being applied to a wider variety of conditions. Skin penetration technologies are being improved by researchers, but this problem will prevent the market from expanding until these developments are widely adopted. Skin Irritation and Sensitivity Significant obstacles in the Asia-Pacific transdermal skin patch industry are skin sensitivity and irritation. Patients may stop wearing the patches regularly if they experience skin problems including rashes, redness, or allergic reactions after using them for an extended period of time. This may limit the market's potential and lower patient compliance. Manufacturers are working to address this by creating hypoallergenic, skin-friendly materials and advancing patch adhesive methods to reduce irritation and improve user comfort, but these issues continue to exist. Key Attributes Report Attribute Details No. of Pages 200 Forecast Period 2024-2033 Estimated Market Value (USD) in 2024 $2.76 Billion Forecasted Market Value (USD) by 2033 $3.96 Billion Compound Annual Growth Rate 4.1% Regions Covered Asia-Pacific Key Topics Covered1. Introduction2. Research & Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Asia-Pacific Transdermal Skin Patches Market5.1 Historical Market Trends5.2 Market Forecast6. Asia-Pacific Transdermal Skin Patches Market Share Analysis6.1 By Type6.2 By Application6.3 By Distribution Channel6.4 By Countries7. Type7.1 Matrix7.2 Reservoir7.3 Drug-in-Adhesive7.4 Other Types8. Application8.1 Pain Relief8.2 Smoking Reduction and Cessation Aid8.3 Overactive Bladder8.4 Hormonal Therapy8.5 Others9. Distribution Channel9.1 Hospital Pharmacies9.2 Retail Pharmacies9.3 Online Pharmacies10. Countries10.1 China10.2 Japan10.3 India10.4 South Korea10.5 Thailand10.6 Malaysia10.7 Indonesia10.8 Australia10.9 New Zealand10.10 Rest of Asia-Pacific11. Porter's Five Forces Analysis11.1 Bargaining Power of Buyers11.2 Bargaining Power of Suppliers11.3 Degree of Rivalry11.4 Threat of New Entrants11.5 Threat of Substitutes12. SWOT Analysis12.1 Strength12.2 Weakness12.3 Opportunity12.4 Threat13. Key Players Analysis13.1 Teva Pharmaceutical Industries Ltd.13.2 3M Company13.3 Nitto Denko Corporation13.4 Johnson & Johnson13.5 Luye Pharma Group13.6 Bayer AG13.7 Novartis AG13.8 Beiersdorf AG13.9 Viatris Inc.13.10 Abbott Laboratories For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Asia-Pacific Transdermal Skin Patches Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

TSX futures inch up ahead of key economic data
TSX futures inch up ahead of key economic data

Yahoo

time44 minutes ago

  • Yahoo

TSX futures inch up ahead of key economic data

(Reuters) -Futures linked to Canada's primary stock index rose slightly on Thursday, as investors awaited economic data from the United States and home to assess the impact of U.S. President Donald Trump's tariffs on the economy and global trade. The S&P/TSX index futures were up 0.2% at 6:35 am ET (1035 GMT). Data scheduled for Thursday are U.S. initial jobless claims and the international trade report at 08:30 a.m. ET. Focus will also be on Friday's employment figures from Canada and non-farm payrolls data from the U.S. to assess the effect of Trump's trade policies on the labour market. Meanwhile, the United States' tariff hike on steel and aluminum took effect on Wednesday. Canada, the largest seller of the metals to the U.S., exports roughly twice as much aluminum as the rest of the top 10 exporters combined. Canadian companies and a major union said higher U.S. tariffs could result in more job losses and lost sales. Prime Minister Mark Carney said Canada is prepared to strike back against the U.S. if talks with Washington to remove tariffs do not succeed. Also on Thursday, China blocked Canada's request to set up a dispute panel to review additional import duties by Beijing on certain Canadian products. Eyes will be on potential negotiations between Washington and its trading partners, with Trump and Chinese leader Xi Jinping expected to speak sometime this week. In commodities, oil and gold prices held steady, while London copper prices inched up. Canada's commodity-linked main stock index fell on Wednesday as lower oil prices weighed on energy shares. FOR CANADIAN MARKETS NEWS, CLICK ON CODES: TSX market report [.TO] Canadian dollar and bonds report [CAD/] [CA/] Reuters global stocks poll for Canada Canadian markets directory

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store